Evidence map›Paper›PMID 33676421›Full record

SynthesisBMC infectious diseases2021

Antibiotic resistance in Pakistan: a systematic review of past decade.

Hazrat Bilal, Muhammad Nadeem Khan, Tayyab Rehman, Muhammad Fazal Hameed, Xingyuan Yang

Abstract readSystematic Review
In one paragraph

Synthesis in BMC infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 92 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
92citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

92 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Diabetes Mellitus and Enhanced Vulnerability toPolish journal of microbiology · 2026
    Article
  7. Article
  8. Unlocking the potential ofFrontiers in microbiology · 2026
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Prevalence and Antibiotic Resistance Pattern ofInfection and drug resistance · 2026
    Article
  16. Whole Genome Sequencing of Drug-ResistantPathogens (Basel, Switzerland) · 2025
    Article
  17. Article
  18. Article
  19. Review
  20. Article

32 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hazrat BilalInstitute of Physical Science and Information Technology, Institute of Health Sciences Anhui University, No, 111 jiulong Road, Hefei, Anhui, 230601, People's Republic of China.
Muhammad Nadeem KhanFaculty of Biological Sciences, Department of Microbiology, Quaid-i-Azam University, Islamabad, 45321, Pakistan.
Tayyab RehmanKhyber Medical University, Institute of Basic Medical Sciences, Department of Medical Microbiology, Peshawar, Khyber Pakhtunkhwa, Pakistan.
Muhammad Fazal HameedInstitute of Physical Science and Information Technology, Institute of Health Sciences Anhui University, No, 111 jiulong Road, Hefei, Anhui, 230601, People's Republic of China.
Xingyuan YangInstitute of Physical Science and Information Technology, Institute of Health Sciences Anhui University, No, 111 jiulong Road, Hefei, Anhui, 230601, People's Republic of China. xingyuan@ahu.edu.cn.ORCID http://orcid.org/0000-0001-8393-4447

Funding

National Natural Science Foundation of China (CN) 31771310Natural Science Foundation of Anhui Province 1708085MC67
6 · The paper itself

Abstract

backgroundDuring the last six decades, extensive use of antibiotics has selected resistant strains, increasing the rate of fatal infectious diseases, and exerting an economic burden on society. This situation is widely accepted as a global problem, yet its degree is not well elucidated in many regions of the world. Up till now, no systemic analysis of Antimicrobial resistance (AMR) in Pakistan has been published. The current study aims to describe the antibiotic-resistance scenario of Pakistan from human samples of the last 10 y, to find the gaps in surveillances and methodology and recommendations for researchers and prescribers founded on these outcomes.

methodsOriginal research articles analyzed the pattern of Antibiotic resistance of any World Health Organization (WHO) enlisted priority pathogens in Pakistan (published onward 2009 till March 2020), were collected from PubMed, Google scholar, and PakMedi Net search engines. These articles were selected based on predefined inclusion and exclusion criteria. Data about the study characteristics and antibiotic-resistance for a given bacterium were excluded from literature. Antibiotic resistance to a particular bacterium was calculated as a median resistance with 95% Confidence Interval (CI).

resultsStudies published in the last 10 y showed that Urinary Tract Infection (UTI) is the most reported clinical diagnosis (16.1%) in Pakistan. E. coli were reported in 28 (30.11%) studies showing high resistance to antibiotics' first line. Methicillin-resistant Staphylococcus aureus (MRSA) was found in 49% of S. aureus' total reported cases. Phenotypic resistance pattern has mostly been evaluated by Disk Diffusion Method (DDM) (82.8%), taken Clinical Laboratory Standards Institute (CLSI) as a breakpoint reference guideline (in 79.6% studies). Only 28 (30.11%) studies have made molecular identification of the resistance gene. blaTEM (78.94% in Shigella spp) and blaNDM-1 (32.75% in Klebsiella spp) are the prominent reported resistant genes followed by VanA (45.53% in Enterococcus spp), mcr-1 (1.61% in Acinetobacter spp), and blaKPC-2 (31.67% in E. coli). Most of the studies were from Sindh (40.86%), followed by Punjab (35.48%), while Baluchistan's AMR data was not available.

conclusionOutcomes of our study emphasize that most of the pathogens show high resistance to commonly used antibiotics; also, we find gaps in surveillances and breaches in methodological data. Based on these findings, we recommend the regularization of surveillance practice and precise actions to combat the region's AMR.

Indexed as

Drug Resistance, BacterialAnimalsAnti-Bacterial AgentsBacteriaHumansPakistanAnti-Bacterial AgentsAntibiotic resistanceBacteriaPakistanSystematic review

Identifiers

PMID33676421
PMCPMC7937258

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.